Plain-English translation of NCT07107022 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a real-world study collecting data on how well the Penumbra System works when used as a first-line treatment for acute ischemic stroke—a type of stroke caused by a blood clot blocking blood flow to the brain. The Penumbra System is a mechanical device designed to remove clots and restore blood flow. Researchers want to understand how this device performs and its safety profile in everyday clinical practice across multiple hospitals worldwide.
Acute ischemic stroke is a medical emergency, and fast removal of blood clots can prevent permanent brain damage and disability. While the Penumbra System is already being used in hospitals, this study gathers real-world data to confirm that the treatment works well and is safe across different patient populations and medical settings.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will receive the Penumbra System as your acute stroke treatment as part of standard emergency care. Following the procedure, you will be asked to complete follow-up assessments and visits over the next 90 days to allow researchers to monitor how well the treatment worked, how you're recovering, and any side effects. The study will be conducted across up to 15 hospital sites globally, enrolling up to 200 patients total.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
Australia
France
Germany